US Patent Issued to Paragon Therapeutics on April 21 for "Alpha4Beta7 integrin binding proteins and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,627, issued on April 21, was assigned to Paragon Therapeutics Inc. (Waltham, Mass.).

"Alpha4Beta7 integrin binding proteins and methods of use" was invented by Eric Franklin Zhu (Waltham, Mass.), Hussam Hisham Shaheen (Waltham, Mass.) and Jacob Cole Milligan (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are Alpha4Beta7 binding proteins (e.g., antibodies that bind Alpha4Beta7) and methods of use."

The patent was filed on June 23, 2025, under Application No. 19/245,760.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u...